Resmed (RMD) Gross Profit (2009 - 2026)

Resmed's Gross Profit history runs 18 years deep, the most recent figure standing at $891.0 million for Q1 2026.

• Quarterly Gross Profit rose 16.25% year-over-year to $891.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 billion (up 15.6% YoY) and the FY2025 annual result came in at $3.1 billion, up 15.05% from the prior year.
• Gross Profit was $891.0 million for Q1 2026 at Resmed, up from $878.7 million in the prior quarter.
• Across five years, Gross Profit topped out at $891.0 million in Q1 2026 and bottomed at $491.2 million in Q1 2022.
• A 5-year average of $686.5 million and a median of $692.8 million in 2024 frame the typical range for Gross Profit.
• Annual changes were most pronounced in 2022 — Gross Profit climbed 6.48% — and 2023, when it rose 25.76%.
• Resmed's Gross Profit stood at $579.7 million in 2022, then increased by 11.6% to $646.9 million in 2023, then climbed by 16.13% to $751.3 million in 2024, then rose by 16.96% to $878.7 million in 2025, then climbed by 1.39% to $891.0 million in 2026.
• Business Quant data shows RMD's Gross Profit at $891.0 million in Q1 2026, $878.7 million in Q4 2025, and $820.8 million in Q3 2025.